Table 2.

Growth inhibitory effects of HepG2 human liver cancer cells by resveratrol and paclitaxel by an MTT

Treatment	OD570 value	Inhibitory rate (%)
Control	0.431 ± 0.003a	/
PA-L	0.322 ± 0.006b	25.3 ± 2.1d
Res + PA-L	0.287 ± 0.008c	33.4 ± 2.2c
PA-H	0.202 ± 0.008d	53.1 ± 2.3b
Res + PA-H	0.089 ± 0.005e	79.4 ± 1.9a

PA-L 5 μg/mL of paclitaxel, Res + PA-L 10 μg/mL of resveratrol +5 μg/mL of paclitaxel, PA-H 10 μg/mL of paclitaxel, Res + PA-H 10 μg/mL of resveratrol +10 μg/mL of paclitaxel

^a-eMean values with different letters in the same column are significantly different (P < 0.05) according to Dunnett’s post-hoc test